Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in Chronic Myeloid Leukemia
-
- Ilaria S. Pagani
- Department of Experimental and Clinical Medicine, Insubria University, Varese, Italy
-
- Orietta Spinelli
- Hematology laboratory, USC Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy
-
- Elia Mattarucchi
- Department of Experimental and Clinical Medicine, Insubria University, Varese, Italy
-
- Cristina Pirrone
- Department of Experimental and Clinical Medicine, Insubria University, Varese, Italy
-
- Diana Pigni
- Department of Experimental and Clinical Medicine, Insubria University, Varese, Italy
-
- Elisabetta Amelotti
- Department of Experimental and Clinical Medicine, Insubria University, Varese, Italy
-
- Silvia Lilliu
- Hematology laboratory, USC Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy
-
- Chiara Boroni
- Hematology laboratory, USC Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy
-
- Tamara Intermesoli
- Hematology laboratory, USC Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy
-
- Ursula Giussani
- Laboratory of Medical Genetics, Papa Giovanni XXIII Hospital, Bergamo, Italy
-
- Luigi Caimi
- Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
-
- Federica Bolda
- Laboratory of chemical-clinical analysis, Section of Hematology and blood coagulation, Stem Cells laboratory, Spedali Civili of Brescia, Brescia, Italy
-
- Renata Baffelli
- Laboratory of chemical-clinical analysis, Section of Hematology and blood coagulation, Stem Cells laboratory, Spedali Civili of Brescia, Brescia, Italy
-
- Eleonora Candi
- Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy
-
- Francesco Pasquali
- Department of Experimental and Clinical Medicine, Insubria University, Varese, Italy
-
- Francesco Lo Curto
- Department of Experimental and Clinical Medicine, Insubria University, Varese, Italy
-
- Arnalda Lanfranchi
- Laboratory of chemical-clinical analysis, Section of Hematology and blood coagulation, Stem Cells laboratory, Spedali Civili of Brescia, Brescia, Italy
-
- Fulvio Porta
- Laboratory of chemical-clinical analysis, Section of Hematology and blood coagulation, Stem Cells laboratory, Spedali Civili of Brescia, Brescia, Italy
-
- Alessandro Rambaldi
- Hematology laboratory, USC Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy
-
- Giovanni Porta
- Department of Experimental and Clinical Medicine, Insubria University, Varese, Italy
収録刊行物
-
- Oncoscience
-
Oncoscience 1 (7), 510-521, 2014-07-23
Impact Journals, LLC